Patent · US Active

Compound useful for the treatment of degenerative and inflammatory diseases

US9505754B2 · kind B2 · utility

9Cited by

4References

22Claims

0Family size

Assignee

Galapagos NV · BE

Inventors

Christel Jeanne Marie Menet · Mechelen, BE
Javier Blanc · Mechelen, BE

Key dates

Filing date	Aug 4, 2014
Grant date	Nov 29, 2016
Priority date	—
Expiry date	Dec 9, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound is disclosed that has a formula represented by the following:This compound may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.